Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 1.1 Form of Placement Agent Agreement
- 4.13 Form of Pre-funded Common Stock Purchase Warrant
- 4.14 Form of Series C Common Stock Purchase Warrant
- 4.15 Form of Series D Common Stock Purchase Warrant
- 5.1 Opinion of Arentfox Schiff, LLP
- 10.23 Securities Purchase Agreement
- 23.1 Consent
- EX-FILING FEES Calculation of Filing Fee Table
- Download Excel data file
- View Excel data file
CNSP similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated April 1, 2024 with respect to the audited financial statements of CNS Pharmaceuticals, Inc. for the years ended December 31, 2023 and 2022. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
We also consent to the references to us under the heading “Experts” in such Registration Statement.
/s/ MaloneBailey, LLP
www.malonebailey.com
Houston, Texas
June 7, 2024